Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study von Zenatri, M., Perennec, T., Michon, C., Gernier, F., Grellard, J.-M., Piloquet, F.-X., Dubot-Poitelon, C., Kalbacher, E., Tredan, O., Augereau, P., Pautier, P., Fey, L., Joly, F., Frenel, J.-S.

Volltext

Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer von Xu-Vuillard, A., Guerin-Charbonnel, C., Bocquet, F., Cheeseman, S., Kubelac, P.M., Zenatri, M., Hall, G., Achimas-Cadariu, P., Hanvic, B., Fenton, H., Sturz-Lazăr, A.-M.-L., Augereau, P., Ray-Coquard, I., Leary, A., Frenel, J.-S.

Volltext

Association between post-operative hPG80 (circulating progastrin) detectable level and worse prognosis in glioblastoma von Doucet, L., Cailleteau, A., Vaugier, L., Gourmelon, C., Bureau, M., Salaud, C., Roualdes, V., Samarut, E., Aumont, M., Zenatri, M., Loussouarn, D., Quillien, V., Bocquet, F., Payen-Gay, L., Joubert, D., Prieur, A., Robert, M., Frenel, J.-S.

Volltext

774P Initial management and long-term outcome of ovarian clear cell carcinoma (OCCC) in the French multicentre ESME database von Zenatri, M., Martin, E., Rodrigues, M.J., Ray-Coquard, I.L., Gladieff, L., Colombo, P-E., Sabatier, R., Joly Lobbedez, F., De La Motte Rouge, T., Pomel, C., Guillemet, C., Petit, T., Fumet, J-D., Lebreton, C., Rossi, L., Pautier, P., Follana, P., Bosquet, L., Frenel, J-S., Augereau, P.

Volltext

46P Long-term residual chemotherapy-induced peripheral neuropathy (CIPN) and relationship with single nucleotide polymorphisms (SNPs) in ovarian cancer patients free of disease in... von Zenatri, M., Perennec, T., Michon, C., Gernier, F., Grellard, J-M., Kalbacher, E., Tredan, O., Augereau, P., Pautier, P., Fey, L., Joly Lobbedez, F., Frenel, J-S.

Volltext